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Abstract
The ABCR gene encodes a rod photoreceptor specific ATP-binding cassette transporter. Mutations in ABCR are associated
with at least four inherited retinal dystrophies: Stargardt disease, Fundus Flavimaculatus, cone-rod dystrophy, and retinitis
pigmentosa. A statistically significant increase in heterozygous ABCR alterations has been identified in patients with age-related
macular degeneration (AMD). A pedigree is described which manifests both Stargardt disease and AMD in which an ABCR
mutation cosegregates with both disease phenotypes. These data from this case report support the hypothesis that ABCR is a
dominant susceptibility locus for AMD. Recent work regarding ABCR is reviewed and a model is presented in which decreased
ABCR function correlates with severity of retinal disease. © 1999 Published by Elsevier Science Ltd. All rights reserved.
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1. Introduction
Age-related macular degeneration (AMD) is the lead-
ing cause of blindness in North America and Europe,
affecting over 25% of individuals over the age of 75
(Bird, Bressler, Bressler, Chisholm, Coscas, Davis et al.,
1995). AMD is a complex disorder which is usually
divided into two clinical categories: (1) exudative or
‘‘wet’’ AMD, characterized by drusen and subsequent
invasion of the retina by blood vessels from the choroid
and:or hemorrhagic detachment of the retina and reti-
nal pigment epithelium (RPE); and (2) atrophic or
‘‘dry’’ AMD, characterized by accumulation of drusen
in and under the RPE and sequential atrophy of the
macular retina and RPE (Bird et al., 1995). Environ-
mental risk factors, including smoking and a high fat
diet, have been associated with AMD (Seddon, Ajani,
Sperduto, Hiller, Blair, Burton et al., 1994; Mares-Perl-
man, Brady, Klein, VandenLangenberg, Klein & Palta,
1995; Christen, Glynn, Manson, Ajani & Buring, 1996;
Seddon, Willett, Speizer & Hankinson, 1996; Delcourt,
Diaz, Ponton-Sanchez & Papoz, 1998). However, these
are not sufficient to explain the high prevalence of
AMD.
1.1. Genetics of AMD
Many studies demonstrate a genetic component of
age-related macular degeneration. The risk for develop-
ing AMD is at least two times higher if an individual
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has a first degree relative with AMD (Seddon, Ajani &
Mitchell, 1997; Klaver, Wolfs, Assink, van Duijn, Hof-
man & de Jong, 1998). Concordance of the AMD
phenotype among monozygotic twins is 100% versus
42% among dizygotic twins (Meyers, Greene & Gut-
man, 1995). However, the paucity of multigenerational
affected families, the late onset of AMD, and the
difficulty of strict definitional phenotypic criteria for
enrollment have hampered identification of causative
genes.
1.2. Single gene disorders as models for multifactorial
disorders
Multifactorial disorders are complex diseases that
have many environmental and genetic causes. One ap-
proach to identify genes involved in multifactorial dis-
orders is to study simple ‘‘model diseases’’ which share
phenotypic characteristics but have a clear genetic ba-
sis. An early example of an association between a
monogenic disorder and a multifactorial disease was
familial hypercholesterolemia. Homozygotes for muta-
tions in the LDL receptor (LDLR) develop extremely
high serum LDL levels and typically die of myocardial
infarction as young adults. Heterozygotes develop mod-
erately high LDL levels and manifest coronary artery
disease in their fourth or fifth decade (Goldstein &
Brown, 1973). Wolfram syndrome (WFS) is an autoso-
mal recessive disorder characterized by diabetes in-
sipidus, diabetes mellitus, optic atrophy, deafness and
psychiatric disorders; 60% of patients experience de-
pression, psychosis or other psychiatric disturbance.
Carriers for WFS exhibit a 26-fold risk for psychiatric
institutionalization (Swift, Polymeropoulos, Torres &
Swift, 1998). Another monogenic disorder, ataxia-
telangiectasia (AT), is characterized by cerebellar
ataxia, telangiectases of the skin, immune dysfunction,
and tumor predisposition. Heterozygous carriers of mu-
tations in ATM, the gene for AT, have an estimated
relative risk of 5.1 to develop breast cancer (Athma,
Rappaport & Swift, 1996). A common recessive disor-
der, cystic fibrosis is characterized primarily by pul-
monary infection, meconeum ileus, and pancreatic
insufficiency. Individuals heterozygous for mutations in
CFTR, possibly the best studied eukaryotic ABC trans-
porter gene, show an increased prevalence of chronic
pancreatitis (Cohn, Friedman, Noone, Knowles, Silver-
man & Jowell, 1998; Sharer, Schwarz, Malone,
Howarth, Painter, Super et al., 1998). In each of these
examples, heterozygous mutations in the causative gene
predispose the carrier to development of a multifacto-
rial disease, whereas homozygous or compound het-
erozygous mutations in the same gene cause a clearly
recessive disorder, usually with an earlier onset and
more severe and definitive clinical phenotype.
1.3. Inherited retinal dystrophies
Many inherited retinal dystrophies with a phenotype
similar to AMD have been described. These include
Best macular dystrophy (OMIM c153700), Sorsby
fundus dystrophy (SFD; OMIM c136900), and auto-
somal dominant radial drusen (Malattia Leventinese:
Doyne honeycomb retinal dystrophy; OMIM
c126600). Cloning of the SFD gene, TIMP3, allowed
testing of its association with AMD. A role for TIMP3
in AMD was excluded by both mutational and linkage
analysis (De La Paz, Pericak-Vance, Lennon, Haines &
Seddon, 1997; Felbor, Doepner, Schneider, Zrenner &
Weber, 1997).
Stargardt disease (STGD) is a juvenile onset recessive
macular dystrophy which is phenotypically similar to
AMD. STGD is characterized by accumulation of pis-
ciform flecks in the mid-peripheral RPE, progressive
atrophy of the central retina and RPE, temporal atro-
phy of the optic disk, and dark choroid on fluorescein
angiography (Stargardt, 1909; Gelisken & De Laey,
1985; Armstrong, Meyer, Xu & Elfervig, 1998). Link-
age studies and analysis of recombinants defined a 2cM
STGD1 locus on 1p13–p21 (Kaplan, Gerber, Larget-
Piet, Rozet, Dollfus, Dufier et al., 1993; Anderson,
Baird, Lewis, Chinault, Otterud, Leppert et al., 1995;
Hoyng, Poppelaars, van de Pol, Kremer, Pinckers,
Deutman et al., 1996). A clinically similar disorder,
Fundus Flavimaculatus (FFM), was mapped to the
STGD1 locus, suggesting that these two disorders are
allelic (Anderson et al., 1995; Gerber, Rozet, Bonneau,
Souied, Camuzat, Dufier et al., 1995). Subsequently, a
gene encoding a retina-specific ATP-binding cassette
transporter (ABCR) was mapped to the STGD1 locus
and mutations were identified in STGD patients (Allik-
mets, Singh, Sun, Shroyer, Hutchinson, Chidambaram
et al., 1997b).
2. ABCR in retinal disease
The ABCR gene contains 50 exons encoding an 8 kb
mRNA transcript with a 6814 bp open reading frame
(Allikmets et al., 1997b; Allikmets, Wasserman,
Hutchinson, Smallwood, Nathans, Rogan et al., 1998;
Azarian, Megarity, Weng, Horvath & Travis, 1998;
Gerber, Rozet, van de Pol, Hoyng, Munnich, Blanke-
nagel et al., 1998). The ABCR protein is identical to
rim protein (RmP), a 220 kDa protein first purified
from photoreceptor outer segments (Papermaster, Con-
verse & Zorn, 1976), based on nucleotide and amino
acid sequence identity and cross-reactivity of antibodies
raised to each protein (Azarian & Travis, 1997; Illing,
Molday & Molday, 1997; Sun & Nathans, 1997). Im-
munohistochemical studies localize ABCR:RmP exclu-
sively to the edge of the disk membranes of the rod
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photoreceptor outer segments (Papermaster, Schneider,
Zorn & Kraehenbuhl, 1978; Sun & Nathans, 1997),
where it is phosphorylated in response to light (Szuts,
1985). Recent data suggest that mice homozygous for a
null allele of ABCR show a delayed recovery after
photobleaching (Weng, Azarian & Travis, 1998). To-
gether, these studies suggest a role for ABCR:RmP in
the photoresponse, possibly as a transporter of 11-cis
retinal or other vitamin A derivatives (Sun, Molday &
Nathans, 1999).
2.1. ABCR mutations in Stargardt disease
A screen for ABCR alterations in 48 unrelated STGD
patients identified 28 mutations in 22 patients, includ-
ing two homozygotes and four compound het-
erozygotes (Allikmets et al., 1997b). This study was
recently extended to include 150 STGD families
screened for all 50 exons of ABCR (Lewis, Shroyer,
Singh, Allikmets, Hutchinson, Li et al., 1999). In this
latter analysis, 183 mutations were identified in 118
patients including three homozygotes and 50 compound
heterozygotes. These data indicate a 57% mutation
detection rate (173 alleles:302 disease chromosomes).
Truncating and missense mutations in the amino termi-
nal portion of the gene were associated with early onset
disease. In ten families (7%) two mutations occurred on
a single chromosome, thus resulting in several complex
alleles. Another study of 55 patients with STGD:FFM
identified 35 mutations in 26 patients (Rozet, Gerber,
Souied, Perrault, Chatelin, Ghazi et al., 1998). Severe
mutations were associated with STGD, while milder
alterations were associated with later onset FFM. These
two reports suggest that severe mutations cause early
onset disease. Other investigations identified 11 muta-
tions in 8 STGD patients (Gerber et al., 1998; Na-
sonkin, Illing, Koehler, Schmid, Molday & Weber,
1998). In total, these studies describe 109 distinct dis-
ease associated alleles and demonstrate the wide hetero-
geneity of mutations in the ABCR gene. Of the 64
patients in whom both mutations were identified (Allik-
mets et al., 1997b; Gerber et al., 1998; Nasonkin et al.,
1998; Rozet et al., 1998; Lewis et al., 1999), none had
two obvious null mutations, suggesting that STGD
patients retain some ABCR activity. These findings
demonstrate that compound heterozygous or ho-
mozygous mutations in ABCR can cause STGD.
2.2. ABCR mutations in AMD
Based on the similar clinical phenotype of STGD and
AMD, including macular degeneration and accumula-
tion of pigmented material in the RPE, it was hypothe-
sized that ABCR alterations may play a role in AMD.
This hypothesis was investigated initially by screening
for ABCR alterations in 167 unrelated patients with
sporadic AMD (Allikmets, Shroyer, Singh, Seddon,
Lewis, Bernstein et al., 1997a). The patient cohort
included 71 patients from Utah and 96 patients from
the Boston area. Heteroduplex and SSCP analysis fol-
lowed by DNA sequencing were used to identify ABCR
alterations in 16% (26:167) of patients, primarily those
with atrophic AMD. Of the 13 mutant alleles identified
in patients with AMD, seven have been described in
STGD patients, suggesting a pathogenic role for these
alterations. The two most common AMD-associated
mutations have similar frequencies in the Utah and
Boston cohorts: D2177N was identified in five patients
from Utah and two patients from Boston; G1961E was
identified in two patients from Utah and four patients
from Boston. These data show similar mutation fre-
quencies in these two patient cohorts and suggest that
these findings are not unique to a genetic isolate but are
applicable generally. The control population consisted
of 220 North American Caucasians ethnically matched
to the AMD patients. Initially, heteroduplex and SSCP
were used to screen the control population for variants
in those exons in which AMD-associated ABCR muta-
tions were found. Subsequently, this screen was ex-
tended to include all 50 exons of ABCR (Dean,
Allimets, Shroyer, Lupski, Lewis, Leppert et al., 1998).
The screen of all 50 exons allows statistical analysis of
the aggregate data, which shows a significant associa-
tion between ABCR mutations and AMD (Dean et al.,
1998). From this association of ABCR mutations with
AMD, it was concluded that some heterozygous ABCR
mutations may predispose to AMD. The interpretation
of these data has been subject to controversy(Dean et
al., 1998; Dryja, Briggs, Berson, Rosenfeld, Abitbol,
Klaver et al., 1998); further analysis is required to
determine the portion of atrophic AMD which is asso-
ciated with ABCR mutations.
2.2.1. ABCR mutations in families with STGD and
AMD
Another approach to investigate the role of ABCR in
AMD is to ascertain families that manifest both STGD
and AMD and determine whether ABCR alterations
cosegregate with both diseases. STGD families with
AMD-affected relatives have been reported (Rozet et
al., 1998; Lewis et al., 1999). Identification of the
underlying ABCR mutations will allow segregation
analysis of these alterations within the families. Coseg-
regation of STGD mutations in AMD relatives would
further support the association between AMD and
ABCR alterations. Here we present a family which
exemplifies this approach.
2.2.1.1. Patients. We have completed mutation analysis
in one family, AR534, which manifests both STGD and
AMD (Fig. 1). The proband, AR534-05, presented with
central visual impairment at age 11. Ophthalmoscopic
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inspection revealed retinal atrophy of the macula and a
few peripheral flecks (Fig. 2B). A dark choroid was
observed on fluorescein angiography, and the diagnosis
of STGD was made. Three paternal cousins are af-
fected with STGD, with onset between the ages of 8
and 10. The proband’s parents reported no visual im-
pairment, but the paternal grandmother had been diag-
nosed previously with age-related macular degeneration
at age 68 (Fig. 2C). Subsequently, she developed hem-
orrhagic detachment of the macula, and a diagnosis of
exudative AMD was made at age 74 (Fig. 2D). All
diagnoses were confirmed by review of clinical records
including color fundus photography and fluorescein
angiography.
2.2.1.2. Methods. Direct DNA sequencing of the 50
exons and flanking intronic regions of ABCR was per-
formed as described (Allikmets et al., 1997a). Heterodu-
plex analysis was performed as described (Allikmets et
al., 1997a). MspI (New England Biolabs, Inc., Beverly,
MA, USA) restriction digestion was performed on PCR
products according to manufacturer’s
recommendations.
2.2.1.3. Results. Direct DNA sequencing of all 50 exons
of ABCR was performed in the proband (05), grand-
mother (07), and a STGD-affected paternal cousin
(10). A summary of the results is shown as Table 1.
Cosegregation of a mutant ABCR allele, P1380L, was
observed with both disease phenotypes (Fig. 1). Muta-
tions in ABCR exons 16 and 28 were identified in
AR534-05, and mutations in ABCR exons 23 and 28
were identified in AR534-10 and -12 (Fig. 1). In addi-
tion, three polymorphisms were observed (Table 1).
Direct sequencing of these exons in all available family
members showed concordant mutations in the parents
of the affected individuals and in the grandparents
AR534-07 and -13 (Fig. 1).
The proband AR534-05 had two independent allelic
mutations: a 4139CT transition which by conceptual
translation results in the missense amino acid substitu-
tion of leucine for proline at codon 1380 (P1380L; Fig.
1); and a 2461TA transversion, resulting in a pre-
dicted amino acid substitution of arginine for tryp-
tophan at codon 821 (W821R; Fig. 1). The proband’s
affected paternal cousins AR534-10 and AR534-12
were each compound heterozygotes for two transition
mutations, one (P1380L; Fig. 1) inherited from their
mother, the other 3364GA, resulting in a predicted
amino acid substitution of lysine for glutamate at
codon 1122 (E1122K; Fig. 1), inherited from their
father. Each base alteration could also be detected by
heteroduplex analysis and segregated as expected (data
not shown). The grandmother AR534-07 with AMD
shared the P1380L mutation (Fig. 1) but had only
polymorphisms in her other ABCR allele, confirming
her heterozygous state. None of these disease-associated
ABCR alterations has been previously identified in our
cohort of patients with AMD. However, the mutation
P1380L has been seen in three unrelated STGD pedi-
grees (Lewis et al., 1999).
To assess disease-association of these ABCR base
alterations, DNA samples from 220 population controls
were screened for variations in exons 16, 23, and 28 by
heteroduplex analysis (data not shown). To investigate
further the frequency of the P1380L allele, which is due
to a base change that eliminates an MspI recognition
site, 80 ophthalmoscopically normal individuals over
the age of 65 were screened for this alteration by MspI
digestion of PCR products encompassing exon 28 (data
not shown). No alterations were identified in any of
these 600 control chromosomes.
Together with the results of Rozet et al., who report
cosegregation of ABCR mutations in two AMD af-
fected grandmothers of STGD patients, these results
support the hypothesis that some heterozygous ABCR
mutations may predispose to AMD (Allikmets et al.,
1997a; Rozet et al., 1998). These findings further sug-
gest that some carrier relatives of STGD patients may
have an increased risk to develop AMD.
2.3. ABCR and other retinal disease phenotypes
Recently, homozygous null mutations in ABCR have
been observed in two consanguineous pedigrees that
manifest autosomal recessive retinitis pigmentosa
(RP19) (Cremers, van de Pol, van Driel, den Hollander,
van Haren, Knoers et al., 1998; Martinez-Mir, Paloma,
Allikmets, Ayuso, del Rio, Dean et al., 1998). In one
family an early frameshift mutation segregates with
disease (Martinez-Mir et al., 1998). In the second pedi-
gree, homozygotes for a null splice mutation manifest
Fig. 1. Pedigree AR534; cosegregation of ABCR mutations with
retinal disease. Circles indicate females, squares indicate males, hori-
zontal bars between indicate mating with children connected below.
Arrow indicates proband. Numbers below each symbol indicate
patients; genotype is depicted below the number.
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Fig. 2. Fundus photographs of subjects AR534-05 and AR534-07 (A) Normal Fundus, age 52. (B) Right Fundus of individual AR534-05 at age
11. Findings in the left Fundus were symmetrical. (C) Left Fundus of individual AR534-07 at age 74. (D) Left Fundus of individual AR534-07
after surgery for exudative detachment of the macula.
retinitis pigmentosa; whereas, compound het-
erozygotes with one null allele and a presumed hypo-
morphic allele manifest an unusual cone-rod
dystrophy, similar to STGD but with severely reduced
ERG and no pigmentary changes (Cremers et al.,
1998). A third pedigree in which the STGD
proband’s mother and maternal uncle manifest retini-
tis pigmentosa has been reported (Lewis et al., 1999).
These data demonstrate that identical ABCR muta-
tions can be associated with more than one retinal
disease phenotype.
3. A model for ABCR activity and retinal disease
To date, ABCR mutations have been described in
five disease phenotypes: retinitis pigmentosa, cone-rod
dystrophy, Stargardt disease, Fundus Flavimaculatus,
and age-related macular degeneration. We propose a
model in which ABCR activity inversely correlates
with severity of disease (Fig. 3). In this model, trun-
cating and severe misfolding mutations are associated
with early onset disease characterized by a primary
photoreceptor loss (retinitis pigmentosa and cone-rod
dystrophy) and secondary RPE defects. In patients
with milder mutations, photoreceptors are spared ini-
tially, but byproducts of faulty ABCR transport lead
to accumulated material in the RPE and sequential
photoreceptor loss (Stargardt disease and Fundus
Flavimaculatus). Finally, ABCR-associated AMD
may be due to the gradual accumulation of these
same byproducts with eventual photoreceptor loss.
This model, in which disease severity is inversely re-
lated to ABCR activity, predicts a potential sequence
of retinal pathology. Now that molecular diagnosis
prior to visual loss is possible, the order of pathologi-
cal events can be examined directly in patients whose
DNA alterations are characterized.
N.F. Shroyer et al. : Vision Research 39 (1999) 2537–25442542
Table 1
Base alteration Amino acid changeIndividual sequence Disease phenotype Mutation type
3364 GA E1122K534-12 MissenseSTGD
P1380L Missense4139 CT
W821R Missense534-05 STGD 2461 TA
4139 CT P1380L Missense
None5682 GC Silent
5814 AG None Silent
None Silent534-07 AMD 3294 CT
4139 CT P1380L Missense
5603 AT N18681* Polymorphism
SilentNone5682 GC
* This base alteration found in 29:220 controls.
4. Conclusions
We reported elsewhere that seven alterations in
ABCR (R1898H, G1961E, 6519del11bp, E471K,
R1129L, 51961GA, and L1970F) are associated
with STGD in compound heterozygous states and
with AMD in an apparent heterozygous state (Allik-
mets et al., 1997a; Lewis et al., 1999). In addition, we
previously showed that the most common mutant
ABCR allele (G1961E) identified in a cohort of 150
families was also one of the most frequently identified
disease associated ABCR alterations in a cohort of
167 AMD patients (Allikmets et al., 1997a; Lewis et
al., 1999). Moreover, association of the same ABCR
mutation with both STGD and AMD suggests that
some family members of STGD patients may have a
higher risk of developing AMD. Here, in addition to
reviewing the literature, we present a case report in
which we show cosegregation of an ABCR mutation
with STGD and AMD in the same family, further
suggesting that STGD and AMD are both phenotypi-
cally and genetically related. Further studies are re-
quired to determine the exact risk for AMD in
carriers of STGD alleles.
Recent biochemical experiments suggest that ABCR
transports a key molecule in the visual cycle—retinal
(Sun et al., 1999). It is not inconceivable that altered
transport of retinal over an extended time period may
be involved in some cases of AMD. Further studies
on large AMD cohorts are required to determine the
extent to which heterozygous ABCR alleles act as a
dominant susceptibility locus for AMD.
It has been observed that mutations in a single
gene can have an important role in multiple clinically
distinct human disorders (e.g., peripherin:RDS in reti-
nal dystrophies (Farrar, Kenna, Jordan, Kumar-
Singh, Humphries, Sharp et al., 1991; Kajiwara,
Sandberg, Berson & Dryja, 1993; Nichols, Sheffield,
Vandenburgh, Drack, Kimura & Stone, 1993; Wells,
Wroblewski, Keen, Inglehearn, Jubb, Eckstein et al.,
1993); MPZ in myelinopathies (Warner, Hilz, Appel,
Killian, Kolodny, Karpati et al., 1996); FGFR2 in
craniosynostosis syndromes(Jabs, Li, Scott, Meyers,
Chen, Eccles et al., 1994; Rutland, Pulleyn, Reardon,
Baraitser, Hayward, Jones et al., 1995; Wilkie, Slaney,
Oldridge, Poole, Ashworth, Hockley et al., 1995;
Przylepa, Paznekas, Zhang, Golabi, Bias, Bamshad et
al., 1996)). These observations of allelic affinity, in
which clinically distinct disorders are caused by differ-
ent mutations in the same gene, and variable expres-
sivity, in which identical mutations may yield
different phenotypes depending on the genetic back-
ground of the individuals, are emerging as common
themes in medical genetics. Finally, these investiga-
tions validate the paradigm of studying rare Mende-
lian disorders to understand common and complex
multifactorial human disorders.
Fig. 3. Phenotypes associated with ABCR mutations. At left, ABCR
activity is represented by the filled triangle and depicts decreasing
activity towards the top. Genotypes are denoted for both chromo-
somes. Null denotes mutations that lead to no functional protein
products including frameshift, nonesense and some splice and mis-
sense mutations. Hypo denotes hypomorphic alleles including most
missense and splice mutations and some C-terminal frameshift and
nonsense mutations. WT denotes wild type or normal alleles. Arrows
indicate association between genotypes and phenotypes; the bracket
indicates that Stargardt disease and Fundus Flavimaculatus may be
caused by either of the indicated genotypes.
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